Mayer Arie has filed 6 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 30000 shares of ORAMED PHARMACEUTICALS INC. ($ORMP) on December 31, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 31, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Mayer Arie | Director | A | Common Stock | 30000 | $0.00 | 163,109.0000 | 42,774,504 | 22.54% | 0.07% |
| Dec. 31, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Mayer Arie | Director | A | Common Stock | 4900 | $0.00 | 168,009.0000 | 42,774,504 | 3.00% | 0.01% |
| June 5, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Mayer Arie | Director | A | Common Stock | 30000 | $0.00 | 126,134.0000 | 41,228,782 | 31.21% | 0.07% |
| June 5, 2025 | ORAMED PHARMACEUTICALS INC. | $ORMP | Mayer Arie | Director | A | Common Stock | 6975 | $0.00 | 133,109.0000 | 41,228,782 | 5.53% | 0.02% |
| Jan. 4, 2024 | ORAMED PHARMACEUTICALS INC. | $ORMP | Mayer Arie | Director | A | Common Stock | 30000 | $0.00 | 86,809.0000 | 40,566,901 | 52.81% | 0.07% |
| Jan. 4, 2024 | ORAMED PHARMACEUTICALS INC. | $ORMP | Mayer Arie | Director | A | Common Stock | 9325 | $0.00 | 96,134.0000 | 40,566,901 | 10.74% | 0.02% |